MedPath

A pilot study to inform a randomised controlled trial of iodine supplementation in preterm infants - iodine rct

Phase 1
Conditions
transient hypothyroxinaemia
Registration Number
EUCTR2005-002404-42-GB
Lead Sponsor
niversity of Dundee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

infants born =<30weeks gestation
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Infants born over 30 weeks gestation. Mothers and infants will be excluded from the study if they are known to be viral hepatitis/HIV positive, have problems giving consent because of mental illness or communication difficulties. Infants with serious congenital anomaly will be excluded.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: 1.We aim to determine whether enteral supplementation with iodine is effective in promoting a positive iodine balance in extreme preterm infants who are parenterally fed.<br>2.To determine the efficacy of the oral versus the nasogastric route of iodine supplementation<br>;Secondary Objective: none;Primary end point(s): iodine balance at postnatal days 7, 14, 28
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath